ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon Print

Japanese company's AI to offer 5-minute dementia diagnosis

Data analysis specialist Fronteo to launch clinical trials early next year

Dementia affects around one-fifth of Japan's elderly, according to the health ministry. By 2025, the country is expected to have around 7 million dementia patients. (Source photo by Wakako Iguchi) 

TOKYO -- Japanese data analysis company Fronteo aims to begin clinical trials as soon as early next year on a diagnostic tool for dementia that uses artificial intelligence.

Fronteo's AI system analyses 5- to 10-minute conversations between a patient and a doctor. The diagnosis itself takes 1 minute. Fronteo hopes to start commercial sales in 2022 of the system, which is designed to minimize stress on both doctors and patients, and help with early diagnosis of dementia.

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more